Skip to main content

Table 2 Average of size, polydipersity index (PDI), zeta potential (ZP) and entrapment effeciency (EE) of the synthesized nanoparticles

From: Hyaluronated nanoparticles deliver raloxifene to CD44-expressed colon cancer cells and regulate lncRNAs/miRNAs epigenetic cascade

NPs type

Ratio

Mean ± SE

EE, %

CS

PVA

HA

Size, nm

PDI

ZP, mV

CS NPs (F1)

(nano-void)

1

0.1

–

98.5 ± 7.3

0.01 ± 0.00

 + 14.5 ± 3.2

–

CS NPs (F2)

(nano-void)

1

0.3

–

180.5 ± 5.5

0.51 ± 0.00

− 8.1 ± 2.5

–

HA-CS NPs

(nano-void)

1

0.1

0.5

118.2 ± 7.7

0.01 ± 0.00

− 14.5 ± 5.1

–

RX-CS NPs (F1)

1

0.1

–

102.5 ± 5.5

0.01 ± 0.00

 + 29.6 ± 4.06

89.5 ± 4.12

RX-CS NPs (F2)

1

0.3

–

212.5 ± 6.5

0.03 ± 0.00

− 9.5 ± 1.02

64.1 ± 3.81

RX-HA-CS NPs

1

0.1

0.5

114.5 ± 5.6

0.04 ± 0.01

-35.3 ± 5.2

90.0 ± 8.12

  1. Data are represented in term of mean ± standard error (SE), n = 3
  2. PDI polydipersity index, ZP zeta potential, EE% entrapment effeciency, RX raloxifene, HA hyaluronic acid, CS chitosan, NPs nanoparticles